Experimental pancreatic cancer pill doubles survival, boosts quality of life
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Pancreatic Cancer Pill Doubles Survival
- Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program Le Monde —
- Revolution Medicines reports Phase 3 win in pancreatic cancer Seeking Alpha —
- Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. ‘I actually started crying’ Fortune —
- New drug nearly doubles survival rates in some pancreatic cancer patients, study says CBS News —
- Why this new pill for a deadly cancer has doctors excited The i Paper —